Susquehanna International Group Portfolio holdings
Susquehanna International Group (SIG), founded in 1987 by Jeff Yass and a group of friends, is a privately held global quantitative trading and technology firm headquartered in Bala Cynwyd, Pennsylvania. Specializing in trading equities, fixed income, commodities, derivatives, and ETFs, SIG has grown into a major market maker, handling around 600 equity options and 45 index options across exchanges like the CBOE, while employing over 3,000 people worldwide. The firm leverages a data-driven, probabilistic approach—rooted in the founders’ poker-playing days—to provide liquidity and competitive pricing in financial markets, with additional ventures in private equity, venture capital (notably an early investment in ByteDance, TikTok’s parent company), and sports betting analytics. Known for its innovative culture and use of game theory, SIG operates offices across North America, Europe, Asia, and Australia, maintaining a low-profile yet influential presence in global finance.
Top Buys
| 1 |
Citigroup
C
|
+$1.03B |
| 2 |
Apple
AAPL
|
+$279M |
| 3 |
AT&T
T
|
+$273M |
| 4 |
Walt Disney
DIS
|
+$225M |
| 5 |
Nike
NKE
|
+$197M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.49B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.16B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$889M |
| 4 |
Advanced Micro Devices
AMD
|
+$865M |
| 5 |
Amazon
AMZN
|
+$763M |
Sector Composition
| 1 | Technology | 15.87% |
| 2 | Consumer Discretionary | 13.03% |
| 3 | Financials | 9.78% |
| 4 | Communication Services | 8.25% |
| 5 | Healthcare | 7.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTEV
1401
Claritev Corporation
CTEV
$1.01B
| $3.62M | ﹤0.01% |
20,430
+10,626
| +108% | +$1.88M |
|
1402
iShares Dow Jones US ETF
IYY
$2.63B
| $3.62M | ﹤0.01% |
30,694
+28,056
| +1,064% | +$3.31M |
|
1403
BioXcel Therapeutics
BTAI
$49.8M
| $3.62M | ﹤0.01% |
11,114
-3,838
| -26% | -$1.25M |
|
1404
Jack Henry & Associates
JKHY
$11.7B
| $3.62M | ﹤0.01% |
21,649
-50,109
| -70% | -$8.37M |
|
1405
iShares MSCI Singapore ETF
EWS
$818M
| $3.61M | ﹤0.01% |
168,619
+55,534
| +49% | +$1.19M |
|
1406
Vanguard FTSE Developed Markets ETF
VEA
$174B
| $3.61M | ﹤0.01% |
70,612
-29,499
| -29% | -$1.51M |
|
|
ANAT
1407
DELISTED
American National Group, Inc. Common Stock
ANAT
| $3.6M | ﹤0.01% |
19,077
+4,578
| +32% | +$865K |
|
|
DMTK
1408
DELISTED
DermTech, Inc. Common Stock
DMTK
| $3.6M | ﹤0.01% |
227,864
+108,547
| +91% | +$1.71M |
|
1409
SPDR Portfolio Developed World ex-US ETF
SPDW
$29.7B
| $3.6M | ﹤0.01% |
98,641
-637
| -0.6% | -$23.2K |
|
1410
Alliant Energy
LNT
$16.7B
| $3.6M | ﹤0.01% |
58,502
+4,031
| +7% | +$248K |
|
1411
Global X Gold Explorers ETF NEW
GOEX
$94.3M
| $3.58M | ﹤0.01% |
122,125
-27,073
| -18% | -$794K |
|
|
ITOS
1412
DELISTED
iTeos Therapeutics
ITOS
| $3.58M | ﹤0.01% |
+76,850
| New | +$3.58M |
|
1413
Invesco DB Precious Metals Fund
DBP
$209M
| $3.57M | ﹤0.01% |
72,871
+43,192
| +146% | +$2.12M |
|
1414
Ascendis Pharma
ASND
$11.8B
| $3.56M | ﹤0.01% |
26,495
+19,920
| +303% | +$2.68M |
|
1415
HCI Group
HCI
$2.34B
| $3.55M | ﹤0.01% |
42,503
-30,709
| -42% | -$2.57M |
|
1416
First Trust Financials AlphaDEX Fund
FXO
$2.26B
| $3.54M | ﹤0.01% |
+76,589
| New | +$3.54M |
|
|
REGI
1417
DELISTED
Renewable Energy Group, Inc.
REGI
| $3.54M | ﹤0.01% |
83,349
+39,030
| +88% | +$1.66M |
|
1418
SandRidge Energy
SD
$420M
| $3.53M | ﹤0.01% |
336,969
-47,034
| -12% | -$492K |
|
1419
Recursion Pharmaceuticals
RXRX
$2.11B
| $3.52M | ﹤0.01% |
205,726
+88,466
| +75% | +$1.52M |
|
1420
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$5.54B
| $3.52M | ﹤0.01% |
65,108
-24,555
| -27% | -$1.33M |
|
1421
KraneShares Global Carbon Strategy ETF
KRBN
$167M
| $3.52M | ﹤0.01% |
69,149
+36,353
| +111% | +$1.85M |
|
|
SRNE
1422
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $3.51M | ﹤0.01% |
754,657
+105,568
| +16% | +$491K |
|
1423
Vanguard S&P 500 ETF
VOO
$740B
| $3.51M | ﹤0.01% |
8,031
+2,357
| +42% | +$1.03M |
|
1424
Riskified
RSKD
$721M
| $3.5M | ﹤0.01% |
+445,068
| New | +$3.5M |
|
|
HGEN
1425
DELISTED
HUMANIGEN, INC.
HGEN
| $3.5M | ﹤0.01% |
939,583
+501,378
| +114% | +$1.86M |
|